Several studies have demonstrated that HSF1 is activated and predicts a poor prognosis in various types of cancer, including breast cancer (Santagata et al., 2011), colon cancer (Jacobs and Marnett, 2009), and liver cancer (Li et al., 2014b). The gene discussed is HSF1; the disease is breast carcinoma.